WRAP53 and lung carcinoma: Given the fact that more than half of the tumors maintained the p53 wild type forms, including lung cancers with the most incidences, our findings not only offer new perspectives in the modulation of senescence by TCAB1 but also suggest a novel therapeutic target for cancer treatment, especially for patients that might failing chemotherapies with risks of over doses.